3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Hypertension
2
Diabetes Mellitus, Type 2
2
Cushing Syndrome
2
ACTH Syndrome, Ectopic
2
Pituitary ACTH Hypersecretion
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
Mifepristone
3
Corlux
3
relacorilant
1
Cabergoline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pituitary ACTH Hypersecretion
×
relacorilant
×
Clear all
NCT03697109
2025-07-16
GRACE
Corcept Therapeutics
Phase 3
Completed
152 enrolled
28 charts